Suchergebnisse - "Clinical Trial, Phase III"

PubPharm (18.684)

51

Patient, family caregiver, and economic outcomes of an integrated screening and novel stepped collaborative care intervention in the oncology setting in the USA (CARES) : a randomised, parallel, phase 3 trial

enthalten in: Lancet (London, England) | 2024

von Steel, J. | George, C. | Terhorst, L. | +19

52

Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18) : a randomised, double-blind, phase 3 clinical trial

enthalten in: Lancet (London, England) | 2024

von Lorusso, D. | Xiang, Y. | Hasegawa, K. | +32

53

Survival, neurocognitive function, and health-related quality of life outcomes after rituximab-methotrexate, BCNU, teniposide, and prednisolone for primary CNS lymphoma : Final results of the HOVON 105/ALLG NHL 24 study

enthalten in: Neuro-oncology | 2024

von Bromberg, J. | Issa, S. | van der Holt, B. | +17

54

Emicizumab prophylaxis in infants with hemophilia A (HAVEN 7) : primary analysis of a phase 3b open-label trial

enthalten in: Blood | 2024

von Pipe, S. | Collins, P. | Dhalluin, C. | +15

CommentIn: Blood. 2024 Apr 4;143(14):1317-1318. - PMID 38573607

55

Immunogenicity and safety of a booster dose of a self-amplifying RNA COVID-19 vaccine (ARCT-154) versus BNT162b2 mRNA COVID-19 vaccine : a double-blind, multicentre, randomised, controlled, phase 3, non-inferiority trial

enthalten in: The Lancet. Infectious diseases | 2024

von Oda, Y. | Kumagai, Y. | Kanai, M. | +8

56

Effective growth hormone replacement with once-weekly somapacitan in Japanese children with growth hormone deficiency : Results from REAL4, a phase 3 clinical trial

enthalten in: Clinical endocrinology | 2024

von Mori, J. | Ohata, Y. | Fujisawa, Y. | +5

57

Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19

enthalten in: The New England journal of medicine | 2024

von Hammond, J. | Fountaine, R. | Yunis, C. | +10

58

XELOX (capecitabine plus oxaliplatin) plus bevacizumab (anti-VEGF-A antibody) with or without adoptive cell immunotherapy in the treatment of patients with previously untreated metastatic colorectal cancer : a multicenter, open-label, randomized, controlled, phase 3 trial

enthalten in: Signal transduction and targeted therapy | 2024

von Pan, Q. | Zhao, J. | Liu, L. | +27

59

KESTREL and KITE Phase 3 Studies : 100-Week Results With Brolucizumab in Patients With Diabetic Macular Edema

enthalten in: American journal of ophthalmology | 2024

von Wykoff, C. | Garweg, J. | Regillo, C. | +12

60

Use of 5-ALA fluorescence-guided surgery versus white-light conventional microsurgery for the resection of newly diagnosed glioblastomas (RESECT study) : a French multicenter randomized phase III study

enthalten in: Journal of neurosurgery | 2024

von Picart, T. | Pallud, J. | Berthiller, J. | +33